-
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.
Nature medicine 20130401
-
The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer.
Thrombosis research 20121101
-
Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101
-
Plasma accumulation of fondaparinux 2.5Â mg in patients after total hip arthroplasty.
Journal of thrombosis and thrombolysis 20121101
-
Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo.
Acta biomaterialia 20121101
-
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery.
European journal of clinical pharmacology 20121001
-
Treatment, survival, and thromboembolic outcomes of thrombotic storm in children.
The Journal of pediatrics 20121001
-
Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.
Neurocritical care 20121001
-
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting.
Thrombosis research 20121001
-
Inferior vena cava thrombectomy in a patient with heparin-induced thrombocytopenia via inflow occlusion technique on beating heart.
Interactive cardiovascular and thoracic surgery 20121001
-
Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry.
Journal of thrombosis and haemostasis : JTH 20121001
-
Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
Journal of thrombosis and haemostasis : JTH 20121001
-
Vaginal delivery in a parturient excessively anticoagulated with fondaparinux.
International journal of obstetric anesthesia 20121001
-
Differential effects of fondaparinux and bemiparin on angiogenic and vasculogenesis-like processes.
Thrombosis research 20120901
-
Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.
Glycobiology 20120901
-
The management of antithrombotic medication in skin surgery.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20120901
-
Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs.
Best practice & research. Clinical haematology 20120901
-
Thrombolytic therapy for submassive pulmonary embolism.
Best practice & research. Clinical haematology 20120901
-
Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin.
Chemistry (Weinheim an der Bergstrasse, Germany) 20120820
-
Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.
Journal of medicinal chemistry 20120809
-
Compartment syndrome due to massive leg hematoma after primary total hip arthroplasty: a previously unreported complication of fondaparinux.
The Journal of arthroplasty 20120801
-
Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
Analytical biochemistry 20120801
-
Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents.
Current cardiology reports 20120801
-
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120801
-
Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery.
Circulation. Cardiovascular interventions 20120801
-
Practice guidelines for reversal of new and old anticoagulants.
Disease-a-month : DM 20120801
-
In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity.
Journal of medicinal chemistry 20120726
-
Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation.
Analytical chemistry 20120703
-
Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment elevation.
Arquivos brasileiros de cardiologia 20120701
-
Reversing anticoagulant therapy.
Current drug discovery technologies 20120601
-
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
Thrombosis and haemostasis 20120601
-
Successful desensitization with un-fractionated heparin in a patient with heparin allergy and tolerance to fondaparinux.
Asian Pacific journal of allergy and immunology 20120601
-
[Thigh haematoma after sciatic nerve block and fondaparinux].
Annales francaises d'anesthesie et de reanimation 20120501
-
Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
Modern rheumatology 20120401
-
In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Thrombosis research 20120401
-
Fondaparinux - data on efficacy and safety in special situations.
Thrombosis research 20120401
-
Dose determination of fondaparinux in healthy cats.
American journal of veterinary research 20120401
-
How should I treat a 'swinging' left main thrombosis complicating coronary angioplasty in an obese, diabetic, elderly woman treated with fondaparinux?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120401
-
Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120315
-
Treatment for superficial thrombophlebitis of the leg.
The Cochrane database of systematic reviews 20120314
-
Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
The Annals of pharmacotherapy 20120301
-
A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization.
Journal of magnetic resonance (San Diego, Calif. : 1997) 20120301
-
[Preclinical and clinical data of the synthetic Xa inhibitor fondaparinux (Arixtra(®))].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20120301
-
Venous thrombosis in emergency department: diagnosis, treatment, and disposition.
European review for medical and pharmacological sciences 20120301
-
Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysis.
Chest 20120201
-
Promise of factor Xa inhibition in acute coronary syndromes.
Current cardiology reports 20120201
-
Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
Thrombosis and haemostasis 20120201
-
Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.
Thrombosis and haemostasis 20120201
-
Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty.
Acta orthopaedica 20120201
-
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.
International journal of hematology 20120201
-
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 20120201
-
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 20120201
-
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 20120201
-
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 20120201
-
Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience.
Thrombosis research 20120101
-
A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.
Journal of thrombosis and thrombolysis 20120101
-
Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats.
The journal of trauma and acute care surgery 20120101
-
Fondaparinux versus enoxaprin in the management of acute coronary syndromes in Switzerland: A cost comparison analysis.
Swiss medical weekly 20120101
-
[Roles of coagulation pathway and factor Xa in chronic kidney disease (CKD)].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101
-
Hitting back HIT.
Annals of cardiac anaesthesia 20120101
-
[Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101
-
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Current medicinal chemistry 20120101
-
Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
The Journal of bone and joint surgery. American volume 20111221
-
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo.
Blood 20111215
-
FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age.
Pediatric blood & cancer 20111201
-
Old and new antithrombotic drugs in neonates and infants.
Seminars in fetal & neonatal medicine 20111201
-
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Journal of thrombosis and haemostasis : JTH 20111201
-
Fondaparinux in acute heparin-induced thrombocytopenia: a case series.
Journal of thrombosis and haemostasis : JTH 20111201
-
Immunogenic but effective: the HIT-fondaparinux brain puzzler.
Journal of thrombosis and haemostasis : JTH 20111201
-
Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates.
Thrombosis and haemostasis 20111201
-
Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
Journal of cardiothoracic and vascular anesthesia 20111201
-
Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
International journal of clinical pharmacy 20111201
-
Transfusions, major bleeding, and prevention of venous thromboembolism with enoxaparin or fondaparinux in thoracic surgery.
Thrombosis and haemostasis 20111201
-
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
The American journal of medicine 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Journal of the American College of Cardiology 20111122
-
Areas of uncertainty in prophylaxis of venous thromboembolism in unselected subjects.
Southern medical journal 20111101
-
Fondaparinux and isolated superficial-vein thrombosis. Of little interest.
Prescrire international 20111101
-
[New anticoagulants].
La Revue du praticien 20111101
-
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.
Science (New York, N.Y.) 20111028
-
Detection of the 1H and 15N NMR resonances of sulfamate groups in aqueous solution: a new tool for heparin and heparan sulfate characterization.
Analytical chemistry 20111015
-
A rare and undesirable complication of heparin-induced thrombocytopenia: acute massive pulmonary embolism.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20111001
-
Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve.
Annals of hematology 20111001
-
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
British journal of clinical pharmacology 20111001
-
The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.
Contact dermatitis 20111001
-
IL-10 modulates fondaparinux inhibition of monocyte-induced thrombin generation.
Journal of thrombosis and thrombolysis 20111001
-
Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study.
Journal of thrombosis and thrombolysis 20111001
-
Anticoagulating obese patients in the modern era.
British journal of haematology 20111001
-
Refractory venous thrombus propagation in the setting of therapeutic anticoagulation.
American journal of physical medicine & rehabilitation 20111001
-
Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.
International journal of hematology 20111001
-
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery.
Minerva anestesiologica 20111001
-
Initiation and reinitiation of anticoagulation therapy.
Seminars in hematology 20111001
-
[Looking for the best molecule. A short history of anticoagulants].
Revue des maladies respiratoires 20111001
-
[Safety and economics of fondaparinux administration in the laparoscopic surgery].
Masui. The Japanese journal of anesthesiology 20111001
-
Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110915
-
Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.
Irish journal of medical science 20110901
-
Effects of antithrombotic drugs fondaparinux and tinzaparin on in vitro proliferation and osteogenic and chondrogenic differentiation of bone-derived mesenchymal stem cells.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110901
-
[Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
Presse medicale (Paris, France : 1983) 20110901
-
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
Journal of thrombosis and haemostasis : JTH 20110901
-
Bioavailability of fondaparinux to critically ill patients.
Journal of critical care 20110801
-
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
Chest 20110801
-
Anticoagulants influence the in vitro activity and composition of shock lymph but not its in vivo activity.
Shock (Augusta, Ga.) 20110801
-
How serious a problem is bleeding in patients with acute coronary syndromes?
Current cardiology reports 20110801
-
Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.
Journal of thrombosis and haemostasis : JTH 20110701
-
Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110701
-
Prolonged anticoagulation with fondaparinux for mechanical cardiac valves in the setting of intracranial hemorrhage.
The Journal of heart valve disease 20110701
-
Detection of a left atrial thrombus under fondaparinux treatment: a case report.
Current drug safety 20110701
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
The Cochrane database of systematic reviews 20110615
-
Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux.
Acute cardiac care 20110601
-
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.
Thrombosis and haemostasis 20110601
-
Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
International angiology : a journal of the International Union of Angiology 20110601
-
Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.
Blood 20110505
-
Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.
Future cardiology 20110501
-
Advances in cardiology: clinical trial update.
Future cardiology 20110501
-
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levels.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110401
-
Preventing postsurgical venous thromboembolism: pharmacological approaches.
Seminars in thrombosis and hemostasis 20110401
-
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate.
British journal of haematology 20110301
-
Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes.
Chinese medical journal 20110301
-
Changes in the concentration of monocytic chemotaxic protein-1 in patients with unstable angina treated with arixtra.
Bulletin of experimental biology and medicine 20110301
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
The Cochrane database of systematic reviews 20110216
-
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives.
Blood 20110210
-
Effects of fondaparinux and a direct factor Xa inhibitor TAK-442 on platelet-associated prothrombinase in the balloon-injured artery of rats.
Journal of cardiovascular pharmacology 20110201
-
Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
Thrombosis research 20110201
-
New anticoagulant agents in acute coronary syndromes.
Heart (British Cardiac Society) 20110201
-
Antithrombotic therapy in ST-segment elevation myocardial infarction.
Expert opinion on pharmacotherapy 20110201
-
Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis.
Thrombosis research 20110201
-
[Recent advances in the treatment of superficial vein thrombosis and extracranial carotid artery stenosis].
Deutsche medizinische Wochenschrift (1946) 20110201
-
Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
The Journal of bone and joint surgery. British volume 20110201
-
Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
Wiener medizinische Wochenschrift (1946) 20110201
-
Treatment of superficial thrombophlebitis.
The New England journal of medicine 20110127
-
Treatment of superficial thrombophlebitis.
The New England journal of medicine 20110127
-
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo.
Blood 20110120
-
Factor Xa inhibitors for acute coronary syndromes.
The Cochrane database of systematic reviews 20110119
-
Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
Thrombosis research 20110101
-
Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model.
Thrombosis and haemostasis 20110101
-
Early postoperative bleeding in polytrauma patients treated with fondaparinux: literature review and institutional experience.
Current vascular pharmacology 20110101
-
Interindividual variability of in vitro response to anticoagulants.
Thrombosis research 20110101
-
Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110101
-
Delayed hypersensitivity challenged by subcutaneous Bemiparin.
Allergologia et immunopathologia 20110101
-
Is there a role for fondaparinux in perioperative bridging?
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110101
-
Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110101
-
[A case of a flapping infected thrombus in the internal jugular vein, septic pneumonias and heparin-induced thrombocytopaenia].
Vnitrni lekarstvi 20110101
-
Heparin-induced thrombocytopenia in the ICU: an overview.
Critical care (London, England) 20110101
-
Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patients.
Circulation journal : official journal of the Japanese Circulation Society 20110101
-
Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia.
Medical science monitor : international medical journal of experimental and clinical research 20110101
-
Roles of coagulation pathway and factor Xa in the progression of diabetic nephropathy in db/db mice.
Biological & pharmaceutical bulletin 20110101
-
[Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
Tuberkuloz ve toraks 20110101
-
Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
Hip international : the journal of clinical and experimental research on hip pathology and therapy 20110101
-
Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.
International journal of nanomedicine 20110101
-
Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20101201
-
[Use of fondaparinux during hemodialysis in heparin-induced thrombocytopenia. About a new observation].
Nephrologie & therapeutique 20101201
-
A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry.
Analytical biochemistry 20101201
-
The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery?
Current opinion in anaesthesiology 20101201
-
New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Clinics in chest medicine 20101201
-
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
American heart journal 20101201
-
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6Â (OASIS-6) trial.
American heart journal 20101201
-
Development and in vivo bioavailability study of an oral fondaparinux delivery system.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101120
-
Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles.
Journal of thrombosis and thrombolysis 20101101
-
Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia.
Interactive cardiovascular and thoracic surgery 20101101
-
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
Thrombosis and haemostasis 20101101
-
Acute pulmonary embolism. Part 2: treatment.
Nature reviews. Cardiology 20101101
-
Pulmonary embolectomy in heparin-induced thrombocytopenia and thrombosis? Safety of heparin use.
Interactive cardiovascular and thoracic surgery 20101101
-
Korean guidelines for the prevention of venous thromboembolism.
Journal of Korean medical science 20101101
-
Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
Hospital practice (1995) 20101101
-
Treating DVT: answers to 7 key questions.
The Journal of family practice 20101101
-
A pilot retrospective comparison of fondaparinux and enoxaparin for the prevention of venous thromboembolism (VTE) in patients with stroke.
Medicine and health, Rhode Island 20101101
-
The HIT treatment in a cardiac surgery patient.
International journal of cardiology 20101029
-
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?
The Journal of arthroplasty 20101001
-
Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Thrombosis research 20101001
-
Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia.
Journal of thrombosis and thrombolysis 20101001
-
Layer-by-layer surface modification of lipid nanocapsules.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20101001
-
Low allergenic potential with fondaparinux: results of a prospective investigation.
Mayo Clinic proceedings 20101001
-
The treatment of venous thromboembolism in patients with cancer.
Internal and emergency medicine 20101001
-
[Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for patients with acute coronary syndrome].
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20101001
-
Fondaparinux: does it cause HIT? Can it treat HIT?
Expert review of hematology 20101001
-
Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
The New England journal of medicine 20100923
-
Superficial phlebitis and phase 3.5 trials.
The New England journal of medicine 20100923
-
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
JAMA 20100922
-
DVT prophylaxis: better living through chemistry: affirms.
Orthopedics 20100907
-
Treatment options in heparin-induced thrombocytopenia.
Current opinion in hematology 20100901
-
Thrombocytopenia during fondaparinux prophylaxis: HIT or something different?
Internal and emergency medicine 20100801
-
Fondaparinux as an alternative anticoagulant therapy during pregnancy.
Journal of thrombosis and haemostasis : JTH 20100801
-
Anticoagulation by factor Xa inhibitors.
Journal of thrombosis and haemostasis : JTH 20100801
-
Population pharmacokinetics of fondaparinux administered at prophylactic doses after major orthopaedic surgery in everyday practice.
Thrombosis and haemostasis 20100801
-
Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested.
Contact dermatitis 20100801
-
Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
Cardiovascular drugs and therapy 20100801
-
Acute pulmonary embolism.
The New England journal of medicine 20100715
-
Venous thromboembolism and cancer: a systematic review.
Journal of thrombosis and thrombolysis 20100701
-
Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100701
-
The complex clinical picture of side effects to anticoagulation.
The Medical clinics of North America 20100701
-
[Fondaparinux and lepirudin as therapeutic alternatives in a disseminated eczematous skin reaction to low-molecular-weight heparin].
Actas dermo-sifiliograficas 20100701
-
[A new deal with new anticoagulants?].
Journal des maladies vasculaires 20100601
-
Deep vein thrombosis: how long will it remain?
Journal of anesthesia 20100601
-
Old versus new anticoagulants: focus on pharmacology.
Recent patents on cardiovascular drug discovery 20100601
-
Adverse drug events associated with disorders of coagulation.
Critical care medicine 20100601
-
Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
Journal of pharmacy practice 20100601
-
[Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
Orvosi hetilap 20100523
-
Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100515
-
Issues in assessing and reducing the risk for venous thromboembolism.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100515
-
Severe bleeding secondary to misuse of fondaparinux: a case report.
Journal of thrombosis and thrombolysis 20100501
-
Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates.
Journal of pharmaceutical and biomedical analysis 20100501
-
Deep vein and intracardiac thrombosis during the post-partum period in Behçet's disease.
International journal of hematology 20100501
-
[Fondaparinux in the treatment of acute coronary syndromes].
Zhonghua xin xue guan bing za zhi 20100501
-
Early discharge of patients with venous thromboembolism: implications regarding therapy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100401
-
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.
Leukemia research 20100401
-
Inhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury.
Clinical and experimental pharmacology & physiology 20100401
-
Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery.
Scandinavian cardiovascular journal : SCJ 20100401
-
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
Thrombosis and haemostasis 20100401
-
Update on fondaparinux: role in management of thromboembolic and acute coronary events.
Cardiovascular & hematological agents in medicinal chemistry 20100401
-
Fondaparinux in major orthopedic surgical patients.
Internal and emergency medicine 20100401
-
Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
International journal of obstetric anesthesia 20100401
-
Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.
The Annals of pharmacotherapy 20100401
-
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Thrombosis research 20100401
-
Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100301
-
Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.
The Journal of thoracic and cardiovascular surgery 20100301
-
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
Journal of thrombosis and haemostasis : JTH 20100301
-
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis.
Internal and emergency medicine 20100201
-
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial.
Journal of thrombosis and haemostasis : JTH 20100201
-
Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience.
American heart journal 20100201
-
Anticoagulant therapy for percutaneous coronary intervention.
Circulation. Cardiovascular interventions 20100201
-
Factor Xa inhibitors in acute coronary syndromes and venous thromboembolism.
Current vascular pharmacology 20100101
-
Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
International journal of obstetric anesthesia 20100101
-
Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.
Analytical biochemistry 20100101
-
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.
European heart journal 20100101
-
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20100101
-
A comparison of three fibrinolytic agents in prevention of intra-abdominal adhesions.
Acta chirurgica Belgica 20100101
-
Heparin-induced thrombocytopenia in a patient treated with fondaparinux.
Clinical advances in hematology & oncology : H&O 20100101
-
Heparin-induced thrombocytopenia associated with fondaparinux.
Clinical advances in hematology & oncology : H&O 20100101
-
Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.
Vascular health and risk management 20100101
-
Fondaparinux: a pharmacoeconomic review of its use in the management of non-ST-segment elevation acute coronary syndrome.
PharmacoEconomics 20100101
-
[Update on current care guidelines: venous thrombosis and pulmonary embolism].
Duodecim; laaketieteellinen aikakauskirja 20100101
-
Heparin-induced thrombocytopenia and cerebral venous thrombosis after low-molecular weight heparin.
Neurology India 20100101
-
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
PharmacoEconomics 20100101
-
Managing bleeding complications in patients treated with the old and the new anticoagulants.
Current pharmaceutical design 20100101
-
The 'chest pain kit' study: A 'pill in the pocket' concept to improve the pre-hospital therapy of acute coronary syndrome.
Cardiology journal 20100101
-
Fondaparinux in acute coronary syndromes.
Expert opinion on drug metabolism & toxicology 20091201
-
Therapeutic use of heparin beyond anticoagulation.
Current drug discovery technologies 20091201
-
Thromboprophylaxis and heparin-induced thrombocytopenia.
British journal of hospital medicine (London, England : 2005) 20091201
-
The case for venous thromboembolism prophylaxis in Africa.
East African medical journal 20091201
-
Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
Circulation 20091117
-
Coagulation factor Xa activates thrombin in ischemic neural tissue.
Journal of neurochemistry 20091101
-
Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.
International journal of hematology 20091101
-
Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
Journal of the American College of Surgeons 20091101
-
From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
Thrombosis and haemostasis 20091101
-
Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
Thrombosis and haemostasis 20091101
-
Binding between heparin and the integrin VLA-4.
Thrombosis and haemostasis 20091101
-
Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
Thrombosis and haemostasis 20091101
-
Thromboprophylaxis after multiple trauma: what treatment and for how long?
Injury 20091101
-
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Journal des maladies vasculaires 20091101
-
Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism.
Journal of thrombosis and thrombolysis 20091001
-
A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss.
American journal of reproductive immunology (New York, N.Y. : 1989) 20091001
-
Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
The Annals of pharmacotherapy 20091001
-
Automated assay for fondaparinux (Arixtra) on the Dade Behring BCS XP.
American journal of clinical pathology 20091001
-
A new era for anticoagulants.
European journal of internal medicine 20091001
-
Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child.
Pediatric blood & cancer 20090901
-
Perioperative anticoagulant management.
The Medical clinics of North America 20090901
-
The benefit of sample pretreatment and use of MS(10) on the Orbitrap for the analysis of pentasaccharides.
Rapid communications in mass spectrometry : RCM 20090901
-
The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
Anesthesia and analgesia 20090901
-
Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090901
-
Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
Health technology assessment (Winchester, England) 20090901
-
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.
Journal of the American College of Cardiology 20090728
-
New antithrombotic agents in acute coronary syndromes.
Current opinion in cardiology 20090701
-
Fondaparinux and epidural anaesthesia.
International journal of obstetric anesthesia 20090701
-
Epidural labor analgesia in a patient receiving fondaparinux.
International journal of obstetric anesthesia 20090701
-
Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion.
The American journal of emergency medicine 20090701
-
Prescription of fondaparinux in hospitalised patients.
Thrombosis and haemostasis 20090601
-
Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes.
The American journal of emergency medicine 20090601
-
Fondaparinux: an overview.
Expert review of cardiovascular therapy 20090601
-
Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.
Current medical research and opinion 20090501
-
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
American heart journal 20090501
-
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Thrombosis and haemostasis 20090401
-
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.
European heart journal 20090301
-
Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.
Thrombosis research 20090301
-
The pain and the gain of treating patients with acute coronary syndromes-can the two be separated?
American heart journal 20090301
-
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
American heart journal 20090301
-
Guideline update. VTE disease: which agents, and when.
The Journal of family practice 20090301
-
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.
Expert review of cardiovascular therapy 20090301
-
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20090301
-
[Advances in antithrombotic treatment--antithrombotics with anti-Xa effect].
Vnitrni lekarstvi 20090301
-
Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey.
Acta orthopaedica 20090226
-
Do we really need an interval between administering fondaparinux and removing a lumbar plexus catheter?
Anesthesia and analgesia 20090201
-
Heparin-induced thrombocytopenia: what clinicians need to know.
Thrombosis and haemostasis 20090201
-
Laboratory monitoring of anticoagulation: where do we stand?
Seminars in thrombosis and hemostasis 20090201
-
Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.
Angiology 20090101
-
Epidural labor analgesia in a patient receiving fondaparinux.
International journal of obstetric anesthesia 20090101
-
[Prevention of deep vein thrombosis in surgical and non-surgical patients].
Hamostaseologie 20090101
-
Fondaparinux: a different weapon in the war on clot: update for the clinical nurse specialist.
Clinical nurse specialist CNS 20090101
-
Heparin-induced thrombocytopenia successfully treated with fondaparinux.
Acta clinica Belgica 20090101
-
Tissue factor and factor v involvement in rat peritoneal fibrosis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101
-
Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome.
PharmacoEconomics 20090101
-
[From old to new anticoagulants: the role of the biologist].
Annales de biologie clinique 20090101
-
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Hematology. American Society of Hematology. Education Program 20090101
-
Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC).
Hematology. American Society of Hematology. Education Program 20090101
-
Prevention and treatment of thromboembolic events in medical patients and new anticoagulants.
Acta clinica Belgica 20090101
-
Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: successful treatment with repeated TIPS and interferon alpha.
Journal of cancer research and therapeutics 20090101
-
Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.
Proceedings of the Western Pharmacology Society 20090101
-
Bias in AJHP supplements.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215
-
Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
Journal of thrombosis and haemostasis : JTH 20081201
-
Postinjury thromboprophylaxis.
Current opinion in critical care 20081201
-
[Pharmacology of heparins and direct anticoagulants].
Hamostaseologie 20081201
-
[Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfuly treated with fondaparinux - a case report].
Kardiologia polska 20081201
-
[Perioperative venous thromboembolism prophylaxis: short review and recommendations].
Annales francaises d'anesthesie et de reanimation 20081201
-
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Circulation 20081111
-
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
American journal of hematology 20081101
-
The use of graduated compression stockings in association with fondaparinux in surgery of the hip: a multicentre, multinational, randomised, open-label, parallel-group comparative study.
The Journal of bone and joint surgery. British volume 20081101
-
The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and myocardial dysfunction in the ischemic heart.
Thrombosis and haemostasis 20081101
-
[Venous thromboembolism and immobilization for medical reason].
Medicina clinica 20081101
-
[Anaesthesia and thromboembolic disease].
Medicina clinica 20081101
-
Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.
Journal of thrombosis and thrombolysis 20081001
-
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
British journal of haematology 20081001
-
Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux.
British journal of anaesthesia 20081001
-
Prevention of venous thromboembolism in hospitalized medical patients.
The Mount Sinai journal of medicine, New York 20081001
-
New anticoagulants.
Current opinion in hematology 20080901
-
Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
American journal of clinical pathology 20080901
-
Venous thromboembolism clinically detected after hip fracture surgery with prophylaxis in a clinical practice setting.
American journal of orthopedics (Belle Mead, N.J.) 20080901
-
Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients.
International orthopaedics 20080801
-
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Clinical orthopaedics and related research 20080801
-
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Thrombosis and haemostasis 20080801
-
Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis.
World journal of gastroenterology 20080728
-
2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies.
The Annals of pharmacotherapy 20080701
-
Which heparin and how much?
Current cardiology reports 20080701
-
Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
Thrombosis and haemostasis 20080701
-
VTE prevention in major orthopedic surgery.
Cleveland Clinic journal of medicine 20080701
-
VTE prevention in major orthopedic surgery.
Cleveland Clinic journal of medicine 20080701
-
Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.
Journal of thrombosis and haemostasis : JTH 20080701
-
Electrochemical recognition of synthetic heparin mimetic at liquid/liquid microinterfaces.
Journal of the American Chemical Society 20080611
-
In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus.
Coronary artery disease 20080601
-
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 20080601
-
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 20080601
-
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 20080601
-
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 20080601
-
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 20080601
-
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes.
Therapeutics and clinical risk management 20080601
-
Successful use of fondaparinux as an alternative anticoagulant in a 2-month-old infant.
Pediatric blood & cancer 20080501
-
Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient.
Cardiology clinics 20080501
-
Prevention of venous thromboembolism in the geriatric patient.
Cardiology clinics 20080501
-
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
Cardiology clinics 20080501
-
The effect of anticoagulant pharmacotherapy on fracture healing.
Expert opinion on pharmacotherapy 20080501
-
Initial management of deep venous thrombosis in the outpatient setting.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080501
-
Heparin-induced thrombocytopenia: a review of current pharmacologic treatment.
Connecticut medicine 20080501
-
Detection of surface bound complement at increasing serum anticoagulant concentrations.
Colloids and surfaces. B, Biointerfaces 20080401
-
Fondaparinux in patients with impaired renal function: the right choice?
Annals of internal medicine 20080401
-
Post-thrombotic syndrome in children: a single center experience.
Journal of pediatric hematology/oncology 20080401
-
Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Thrombosis and haemostasis 20080401
-
Fondaparinux for the prevention or treatment of venous thromboembolism related to lower limb trauma: evidence today.
Current vascular pharmacology 20080401
-
Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study.
International journal of clinical pharmacology and therapeutics 20080401
-
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080401
-
Prevention of venous thromboembolism in the orthopedic surgery patient.
Cleveland Clinic journal of medicine 20080401
-
Venous thromboembolism (VTE).
Cleveland Clinic journal of medicine 20080401
-
Prevention of venous thromboembolism in the cancer surgery patient.
Cleveland Clinic journal of medicine 20080401
-
New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications.
Vascular health and risk management 20080401
-
[Fondaparinux: the present and the future].
Pathologie-biologie 20080301
-
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Clinical orthopaedics and related research 20080301
-
Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin.
Journal of the European Academy of Dermatology and Venereology : JEADV 20080301
-
Standardizing the management of heparin-induced thrombocytopenia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080215
-
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
European heart journal 20080201
-
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
European heart journal 20080201
-
[New anticoagulants].
Hamostaseologie 20080201
-
Recent developments in acute coronary syndromes.
Clinical medicine (London, England) 20080201
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
The Cochrane database of systematic reviews 20080123
-
Fondaparinux: use in thromboprophylaxis of acute medical patients.
Drugs & aging 20080101
-
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Thrombosis and haemostasis 20080101
-
Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Thrombosis and haemostasis 20080101
-
Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Thrombosis research 20080101
-
Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
The International journal of artificial organs 20080101
-
Primary prophylaxis of venous thromboembolism in surgical patients.
Vascular and endovascular surgery 20080101
-
The in vitro anticoagulant effects of danaparoid, fondaparinux, and lepirudin in children compared to adults.
Thrombosis research 20080101
-
Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101
-
Factor Xa inactivation in acute coronary syndrome.
Current pharmaceutical design 20080101
-
Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.
Thrombosis research 20080101
-
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.
Journal of experimental & clinical cancer research : CR 20080101
-
[Guidelines for prevention of venous thromboembolism in Austria].
Wiener klinische Wochenschrift 20080101
-
[Novel anticoagulant fondaparinux in the treatment of acute coronary syndrome].
Kardiologiia 20080101
-
Spotlight on fondaparinux sodium in acute coronary syndromes.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20080101
-
New anticoagulants in children.
Hematology. American Society of Hematology. Education Program 20080101
-
[Fondaparinux and invasive treatment of non-ST elevation acute coronary syndrome].
Kardiologiia 20080101
-
Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux.
Acta haematologica 20080101
-
[Venous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study].
Acta orthopaedica et traumatologica turcica 20080101
-
Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery.
The European journal of health economics : HEPAC : health economics in prevention and care 20071201
-
Inhibition of thrombin generation in recalcified plasma.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071201
-
The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study.
Anesthesia and analgesia 20071201
-
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.
Thrombosis and haemostasis 20071201
-
Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism.
Thrombosis and haemostasis 20071201
-
Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions.
Thrombosis and haemostasis 20071201
-
Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20071201
-
Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071115
-
Efficacy and safety of fondaparinux in patients with acute coronary syndromes.
Expert review of cardiovascular therapy 20071101
-
Nonbleeding complications of unfractionated and low-molecular weight heparins.
Clinical advances in hematology & oncology : H&O 20071101
-
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
Journal of the American College of Cardiology 20071030
-
Monitoring fondaparinux with the Sonoclot.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071001
-
The pharmacoeconomics of deep vein thrombosis treatment.
The American journal of medicine 20071001
-
[Heparin-induced thrombocytopenia].
Revista espanola de cardiologia 20071001
-
[Optimizing antithrombotic therapy in non-ST-elevation acute coronary syndrome].
Revista espanola de cardiologia 20071001
-
The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
The American journal of cardiology 20070915
-
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
Annals of internal medicine 20070904
-
The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options.
Journal of surgical oncology 20070901
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison.
Journal of thrombosis and haemostasis : JTH 20070901
-
Extended travel after hip arthroplasty surgery. Is it safe?
The Journal of arthroplasty 20070901
-
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Current cardiology reports 20070901
-
[Heparin-induced thrombocytopenia: a brief update in an Italian perspective].
Recenti progressi in medicina 20070901
-
Treatment of thrombosis with fondaparinux (Arixtra) in a patient with end-stage renal disease receiving hemodialysis therapy.
Journal of pediatric hematology/oncology 20070801
-
Beyond unfractionated heparin and warfarin: current and future advances.
Circulation 20070731
-
Prophylaxis for thromboembolism in hospitalized medical patients.
The New England journal of medicine 20070719
-
New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction.
Current cardiology reports 20070701
-
Enzymatic synthesis of glycosaminoglycan heparin.
Seminars in thrombosis and hemostasis 20070701
-
Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
Seminars in thrombosis and hemostasis 20070701
-
The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study.
The Journal of bone and joint surgery. British volume 20070701
-
Heparin-induced thrombocytopenia associated with fondaparinux.
The New England journal of medicine 20070621
-
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux.
Journal of thrombosis and thrombolysis 20070601
-
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Journal of thrombosis and haemostasis : JTH 20070601
-
Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070601
-
Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
Pharmacotherapy 20070601
-
[Standards and perspectives for thromboembolism prophylaxis].
Der Orthopade 20070601
-
Bioengineering novel in vitro metabolic pathways using synthetic biology.
Current opinion in microbiology 20070601
-
[Fondaparinux in the treatment of pulmonary thromboembolism: MATISSE study].
Revista clinica espanola 20070601
-
Management of acute coronary syndromes with fondaparinux.
Vascular health and risk management 20070601
-
Prevention and treatment of venous thromboembolism in the elderly patient.
Clinical interventions in aging 20070601
-
[Initial treatment of venous thromboembolic events].
La Revue du praticien 20070415
-
Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients.
The New England journal of medicine 20070405
-
Fondaparinux: pharmacology and clinical experience in cardiovascular medicine.
Mini reviews in medicinal chemistry 20070401
-
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
International journal of clinical pharmacology and therapeutics 20070401
-
High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions.
Biochemistry 20070320
-
Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070301
-
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
Thrombosis and haemostasis 20070301
-
Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
Thrombosis and haemostasis 20070301
-
Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
Thrombosis and haemostasis 20070301
-
Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
The Netherlands journal of medicine 20070301
-
[Fondaparinux--evolution or revolution in anticoagulant care?].
Polskie Archiwum Medycyny Wewnetrznej 20070301
-
New anticoagulants: from bench to bedside.
Hamostaseologie 20070201
-
American Society of Hematology--48th Annual Meeting and Exposition. The Factor Xa target, and disorders of platelet number and function. 9-12 December 2006 Orlando, FL, USA.
IDrugs : the investigational drugs journal 20070201
-
Coagulation factor Xa modulates airway remodeling in a murine model of asthma.
American journal of respiratory and critical care medicine 20070115
-
Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy.
Thrombosis research 20070101
-
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro.
Thrombosis research 20070101
-
Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
Thrombosis and haemostasis 20070101
-
Fondaparinux in the management of recurrent venous thromboembolic events in a patient with active lung cancer.
Thrombosis research 20070101
-
Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Thrombosis research 20070101
-
[Prevention of venous thromboembolism in orthopedic surgery and traumatology].
Recenti progressi in medicina 20070101
-
[Diagnosis and management of deep venous thrombosis].
Revista de medicina de la Universidad de Navarra 20070101
-
Heparin-induced thrombocytopenia: a general review.
Journal of infusion nursing : the official publication of the Infusion Nurses Society 20070101
-
Retroperitoneal hematoma due to spontaneous lumbar artery rupture during fondaparinux treatment. Case report and review of the literature.
Acta bio-medica : Atenei Parmensis 20070101
-
Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Reviews in cardiovascular medicine 20070101
-
Current challenges of anticoagulant treatment.
Romanian journal of internal medicine = Revue roumaine de medecine interne 20070101
-
[Recurrent pulmonary embolism in a patient with heparin-induced thrombocytopenia].
Polskie Archiwum Medycyny Wewnetrznej 20070101
-
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
The Journal of pathology 20061201
-
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury.
Thrombosis and haemostasis 20061201
-
Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
Vascular health and risk management 20061201
-
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.
Vascular health and risk management 20061201
-
Thromboprophylaxis in major abdominal surgery for cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20061101
-
Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing.
Archives of pathology & laboratory medicine 20061101
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.
JAMA 20061101
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.
JAMA 20061101
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.
JAMA 20061101
-
Bleeding in acute coronary syndromes.
Timely topics in medicine. Cardiovascular diseases 20061101
-
Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
The Journal of heart valve disease 20061101
-
Prevention of venous thromboembolism.
Seminars in thrombosis and hemostasis 20061101
-
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No.
Journal of thrombosis and haemostasis : JTH 20061001
-
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Arteriosclerosis, thrombosis, and vascular biology 20061001
-
The influence of new antithrombotic drugs on regional anesthesia.
Current opinion in anaesthesiology 20061001
-
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? Yes.
Journal of thrombosis and haemostasis : JTH 20061001
-
Evidence for the prevention of venous thromboembolism.
British journal of nursing (Mark Allen Publishing) 20061001
-
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy.
Blood 20060901
-
Emerging anticoagulants for the treatment of venous thromboembolism.
Thrombosis and haemostasis 20060901
-
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism.
The American journal of cardiology 20060815
-
Treatment dosage recommendation for fondaparinux in a patient with heparin induced thrombocytopenia.
Journal of thrombosis and thrombolysis 20060801
-
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.
Expert opinion on investigational drugs 20060801
-
Heparin-induced thrombocytopenia and cardiovascular diseases.
American heart journal 20060701
-
Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia.
Journal of thrombosis and haemostasis : JTH 20060701
-
Safer alternative to heparin identified.
Health news (Waltham, Mass.) 20060701
-
Advances in antithrombotic therapy in acute myocardial infarction: the ExTRACT-TIMI 25 and OASIS-6 Trials.
Current cardiology reports 20060701
-
Fondaparinux versus enoxaparin in acute coronary syndromes.
The New England journal of medicine 20060629
-
Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
Allergy 20060601
-
[Deep vein thrombosis: new drugs and future therapeutic perspectives].
Revista clinica espanola 20060601
-
Development and clinical evaluation of two chromogenic substrate methods for monitoring fondaparinux sodium.
Therapeutic drug monitoring 20060601
-
Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
The Annals of pharmacotherapy 20060501
-
Role of current and emerging antithrombotics in thrombosis and cancer.
Drugs of today (Barcelona, Spain : 1998) 20060501
-
NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients.
Journal of the National Cancer Institute 20060419
-
Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
The New England journal of medicine 20060406
-
Therapy for patients with acute coronary syndromes--new opportunities.
The New England journal of medicine 20060406
-
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
JAMA 20060405
-
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
JAMA 20060405
-
Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.
Journal of the American Society for Mass Spectrometry 20060401
-
[Prevention of venous thromboembolism in older acute hospitalized patients].
Kardiologia polska 20060401
-
Evaluation of wound healing after total knee arthroplasty in a randomized prospective trial comparing fondaparinux with enoxaparin.
The Knee 20060301
-
The effect of different anticoagulants on thrombin generation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060301
-
Fondaparinux as anticoagulant in a pregnant woman with heparin allergy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060301
-
The effect of fondaparinux versus enoxaparin in the survival of a congested skin flap in a rabbit model.
Annals of plastic surgery 20060301
-
Disappearance of anti-PF4/heparin antibodies under prolonged fondaparinux administration in a patient with DVT associated with LMWH-induced thrombocytopenia.
Thrombosis and haemostasis 20060301
-
[Prevention of venous thromboembolism: generally accepted guidelines].
Vnitrni lekarstvi 20060301
-
[Prevention of venous thromboembolism in orthopaedics].
Vnitrni lekarstvi 20060301
-
Clinical trials of new anticoagulants.
Vnitrni lekarstvi 20060301
-
New oral anticoagulants show promise.
JAMA 20060215
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
BMJ (Clinical research ed.) 20060211
-
Venous thromboembolism: heparins are of porcine origin.
BMJ (Clinical research ed.) 20060211
-
Heparins, low-molecular-weight heparins, and pentasaccharides.
Clinics in geriatric medicine 20060201
-
Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Expert opinion on pharmacotherapy 20060201
-
New concepts in heparin-induced thrombocytopenia: diagnosis and management.
Journal of thrombosis and thrombolysis 20060201
-
Venous thromboembolism.
BMJ (Clinical research ed.) 20060128
-
Factor Xa inhibitors: new anti-thrombotic agents and their characteristics.
Frontiers in bioscience : a journal and virtual library 20060101
-
Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty.
The Journal of bone and joint surgery. British volume 20060101
-
The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin.
Structure (London, England : 1993) 20060101
-
[Patient with antithrombotic medication. Which do bleedings or preoperative?].
Laryngo- rhino- otologie 20060101
-
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.
The Journal of arthroplasty 20060101
-
Blood thinner cuts risk of bleeding in half.
Health news (Waltham, Mass.) 20060101
-
Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20060101
-
Anticoagulation via anti-Factor Xa inhibition.
Lupus 20060101
-
Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
The Annals of pharmacotherapy 20060101
-
Thromboprophylaxis in medical patients--why not for all?
Pathophysiology of haemostasis and thrombosis 20060101
-
[Thrombocytopenia probably heparin-induced in women with tumor of the heart and pulmonary embolism].
Pneumonologia i alergologia polska 20060101
-
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
Blood 20051201
-
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 20051201
-
Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux.
Journal of thrombosis and haemostasis : JTH 20051201
-
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Thrombosis and haemostasis 20051201
-
New anticoagulants for venous thromboembolic disease.
Current opinion in cardiology 20051101
-
[Is there a difference between low-molecular-weight heparins?].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20051020
-
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
The British journal of surgery 20051001
-
A postal survey of current thromboprophylactic practices of consultant orthopaedic surgeons in the treatment of fracture of the hip.
The Journal of bone and joint surgery. British volume 20051001
-
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 20051001
-
Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy.
Thrombosis and haemostasis 20051001
-
Homonymous hemianopia caused by occipital lobe infarction in heparin-induced thrombocytopenia and thrombosis syndrome.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20050901
-
Heparin and other rapidly acting anticoagulants.
Seminars in vascular surgery 20050901
-
[Thrombosis prophylaxis and rational pharmacotherapy].
Ugeskrift for laeger 20050815
-
New antithrombotics in the prevention of thromboembolic disease.
European journal of internal medicine 20050801
-
Fondaparinux: a potential new therapy for HIT.
Hematology (Amsterdam, Netherlands) 20050801
-
Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.
Chest 20050801
-
[Monitoring anticoagulation by fondaparinux: determination of anti factor Xa-level].
Hamostaseologie 20050801
-
Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Seminars in vascular medicine 20050801
-
Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Seminars in vascular medicine 20050801
-
[Primary prevention of deep vein thrombosis in non-surgical patients].
Deutsche medizinische Wochenschrift (1946) 20050715
-
The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
Expert opinion on drug safety 20050701
-
Short- and long-acting synthetic pentasaccharides as antithrombotic agents.
Expert opinion on investigational drugs 20050701
-
[Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
Ugeskrift for laeger 20050523
-
[The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
Ugeskrift for laeger 20050523
-
Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux.
Thrombosis and haemostasis 20050501
-
Minimising the risk of heparin-induced osteoporosis during pregnancy.
Expert opinion on drug safety 20050501
-
Optimizing antiplatelet and anticoagulant agents in the perioperative orthopedic surgery patient.
Orthopedics 20050501
-
Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid.
The Netherlands journal of medicine 20050501
-
Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats.
Acta anaesthesiologica Scandinavica 20050401
-
[Innovation instead of imitation -- news in drug therapy].
Deutsche medizinische Wochenschrift (1946) 20050401
-
Current and emerging options in the management of venous thromboembolism.
Cleveland Clinic journal of medicine 20050401
-
Cost considerations surrounding current and future anticoagulant therapies.
Cleveland Clinic journal of medicine 20050401
-
[Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs].
Recenti progressi in medicina 20050401
-
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
Circulation 20050322
-
Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
Allergy 20050301
-
From heparins to factor Xa inhibitors and beyond.
European journal of clinical investigation 20050301
-
Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events.
European journal of clinical investigation 20050301
-
Fondaparinux: an update on new study results.
European journal of clinical investigation 20050301
-
The 'precautionary principle' as a guide for future drug development.
European journal of clinical investigation 20050301
-
The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury.
Journal of thrombosis and haemostasis : JTH 20050301
-
New anticoagulants for the prevention and treatment of venous thromboembolism.
Vascular health and risk management 20050301
-
Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro.
The British journal of surgery 20050201
-
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
Hematology/oncology clinics of North America 20050201
-
Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050201
-
The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
Chest 20050201
-
New ways to prevent venous thromboembolism--the pentasaccharide fondaparinux and the thrombin inhibitor ximelagatran--a review.
Acta chirurgica Belgica 20050201
-
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.
Blood 20050101
-
Thrombin-directed inhibitors: pharmacology and clinical use.
American heart journal 20050101
-
Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolism.
Drugs 20050101
-
[Fondaparinux--a good therapeutic alternative. Interesting pharmacological action for thrombosis prevention in orthopedic surgery].
Lakartidningen 20050101
-
Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
-
Fondaparinux.
Current pharmaceutical design 20050101
-
The treatment of deep venous thrombosis, including the newer agents.
Disease-a-month : DM 20050101
-
Management of pulmonary embolism in 2005.
Disease-a-month : DM 20050101
-
Severe thrombocytopenia after heparin therapy in a patient with unstable angina and recent stent implantation.
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20050101
-
Inhibition of Factor Xa : a potential target for the development of new anticoagulants.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
-
Anticoagulant use in patients with chronic renal impairment.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
-
Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
-
[Novel possibilities of antithrombotic therapy in patients with chronic heart failure].
Kardiologiia 20050101
-
[New antithrombotic drugs: fondaparinux, idraparinux, ximelagatran].
Przeglad lekarski 20050101
-
Clinical trials of deep vein thrombosis prophylaxis in medical patients.
Clinical cornerstone 20050101
-
[New anticoagulants in clinical practice].
Orvosi hetilap 20041205
-
In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile.
Thrombosis and haemostasis 20041201
-
Economic considerations in the prevention and treatment of venous thromboembolism.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041201
-
Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Seminars in thrombosis and hemostasis 20041201
-
Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Thrombosis and haemostasis 20041101
-
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
Circulation 20041019
-
Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies.
Current medicinal chemistry. Cardiovascular and hematological agents 20041001
-
Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.
Archives of pathology & laboratory medicine 20041001
-
Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in elective hip replacement surgery.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20041001
-
Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients.
The Journal of arthroplasty 20041001
-
Preparing for the post-warfarin generation of antithrombotics.
The American journal of managed care 20041001
-
Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.
Current opinion in pulmonary medicine 20040901
-
Prophylaxis of venous thromboembolism in medical patients.
Current opinion in pulmonary medicine 20040901
-
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 20040901
-
Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux.
Contact dermatitis 20040901
-
New anticoagulants for treatment of venous thromboembolism.
Circulation 20040831
-
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
Chest 20040801
-
Challenges in the prevention of venous thromboembolism in the elderly.
Journal of thrombosis and haemostasis : JTH 20040801
-
Pentasaccharides. The new anticoagulants.
Saudi medical journal 20040801
-
New trends in anticoagulant therapy.
The Israel Medical Association journal : IMAJ 20040801
-
Treatment of heparin-induced thrombocytopenia with fondaparinux.
Haematologica 20040801
-
Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
Contact dermatitis 20040801
-
[Prevention and treatment of deep vein thrombosis with ximelagatran].
Deutsche medizinische Wochenschrift (1946) 20040723
-
Limitations of traditional anticoagulants.
Pharmacotherapy 20040701
-
Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data.
Pharmacotherapy 20040701
-
Evidence for extended prophylaxis in the setting of orthopedic surgery.
Pharmacotherapy 20040701
-
Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.
Pharmacotherapy 20040701
-
Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.
Pharmacotherapy 20040701
-
Pharmacoeconomics of thrombosis management.
Pharmacotherapy 20040701
-
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.
Journal of the American College of Cardiology 20040616
-
A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
Angewandte Chemie (International ed. in English) 20040614
-
[Modern anticoagulation. Problems of the proven, hope for the new].
Der Internist 20040601
-
Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.
Journal of thrombosis and haemostasis : JTH 20040601
-
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.
Expert opinion on pharmacotherapy 20040601
-
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Annals of internal medicine 20040601
-
Summaries for patients. Fondaparinux or enoxaparin for deep venous thrombosis?
Annals of internal medicine 20040601
-
Intolerance of fondaparinux in a patient allergic to heparins.
Contact dermatitis 20040601
-
[The new anticoagulants are here!].
Revue des maladies respiratoires 20040601
-
The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
International journal of clinical practice 20040501
-
Minor transplacental passage of fondaparinux in vivo.
The New England journal of medicine 20040429
-
Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
Thrombosis and haemostasis 20040301
-
[Prevention of deep vein thrombosis in surgical departments].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20040301
-
Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040301
-
Current perspectives on the treatment of venous thromboembolism: need for effective, safe and convenient new antithrombotic drugs.
International journal of clinical practice 20040301
-
Fondaparinux: a new synthetic and selective inhibitor of Factor Xa.
Best practice & research. Clinical haematology 20040301
-
[Hemostasis-altering drugs and regional anesthetic techniques: safety guidelines].
Revista espanola de anestesiologia y reanimacion 20040301
-
Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo.
Blood 20040215
-
Fondaparinux in pulmonary embolism.
The New England journal of medicine 20040205
-
Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy.
Allergy 20040201
-
Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity.
Journal of thrombosis and haemostasis : JTH 20040201
-
Fondaparinux for symptomatic pulmonary embolism.
The New England journal of medicine 20040108
-
A cost analysis of fondaparinux versus enoxaparin in total knee arthroplasty.
American journal of therapeutics 20040101
-
Fondaparinux sodium lacks immunomodulatory effects of heparin.
American journal of surgery 20040101
-
Arixtra (fondaparinux sodium).
Methods in molecular medicine 20040101
-
[On fondaparinux and anesthesia ].
Revista espanola de anestesiologia y reanimacion 20040101
-
Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery.
American journal of therapeutics 20040101
-
Treatment of venous thromboembolism: duration and new options.
The hematology journal : the official journal of the European Haematology Association 20040101
-
[Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors].
Pharmazie in unserer Zeit 20040101
-
[Low molecular weight heparin, fondaparinux and melagatran: new data and clinical studies].
Pharmazie in unserer Zeit 20040101
-
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
PharmacoEconomics 20040101
-
Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
Drugs 20040101
-
Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101
-
Advances in DVT prophylaxis and management in major orthopaedic surgery.
Surgical technology international 20040101
-
[Novel antithrombotic drugs. From the 19th Congress of the International Society on Thrombosis and Haemostasis].
Kardiologiia 20040101
-
Current options in the prevention of thromboembolic disease.
Drugs 20040101
-
Fondaparinux.
The Journal of the American Academy of Orthopaedic Surgeons 20040101
-
[Prevention and treatment of venous thromboses and thromboembolism: pentasaccharides as novel anticoagulants selectively blocking Xe factor, their position and potential (data of the XIX International Congress on Thromboses and Hemostasis)].
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20040101
-
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Surgical technology international 20040101
-
Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Acta clinica Belgica 20040101
-
Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization.
Allergy 20031201
-
Fondaparinux and prolonged thromboprophylaxis after hip fracture surgery.
Archives of internal medicine 20031201
-
Advances and contemporary issues in prophylaxis for deep vein thrombosis.
Chest 20031201
-
New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology.
Chest 20031201
-
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Chest 20031201
-
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
Chest 20031201
-
Duration of venous thromboembolism prophylaxis after surgery.
Chest 20031201
-
[Prevention of venous thromboembolism after major orthopedic surgery: update and contribution of a specific synthetic inhibitor of factor Xa].
Revue de chirurgie orthopedique et reparatrice de l'appareil moteur 20031201
-
Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Contact dermatitis 20031201
-
[New anticoagulant preparation Arixtra. Experience and perspectives of clinical application].
Klinichna khirurhiia 20031201
-
Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet (London, England) 20031108
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet (London, England) 20031108
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet (London, England) 20031108
-
[Synthetic anticoagulation stands the test in internist patients, Thrombosis risk in immobilization cut in half].
MMW Fortschritte der Medizin 20031106
-
Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
The Annals of pharmacotherapy 20031101
-
[New anticoagulants in the treatment of venous thrombo-embolic disease].
La Revue de medecine interne 20031101
-
Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins.
Haematologica 20031101
-
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Journal of thrombosis and haemostasis : JTH 20031101
-
Successful use of Arixtra in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia.
Journal of thrombosis and haemostasis : JTH 20031101
-
Thrombosis and Hemostasis Issues in Cancer - Second International Conference. 19-21 September, 2003, Bergamo, Italy.
IDrugs : the investigational drugs journal 20031101
-
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
The New England journal of medicine 20031030
-
Treating thrombosis in the 21st century.
The New England journal of medicine 20031030
-
Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts.
Calcified tissue international 20031001
-
Short- and long-acting synthetic pentasaccharides.
Journal of internal medicine 20031001
-
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031001
-
The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery.
Journal of thrombosis and haemostasis : JTH 20031001
-
Best evidence in anesthetic practice: prevention: fondaparinux is better than enoxaparin for prevention of major venous thromboembolism after orthopedic surgery.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20031001
-
Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide.
The Journal of biological chemistry 20030912
-
Fondaparinux, the first selective factor Xa inhibitor.
Current opinion in hematology 20030901
-
Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity.
Journal of thrombosis and haemostasis : JTH 20030901
-
Efficacy of pentasaccharide on a prethrombosis model based on a calibrated stasis by the increase in up-stream venous pressure.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20030901
-
Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
Contact dermatitis 20030901
-
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
Lancet (London, England) 20030816
-
Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
Thrombosis and haemostasis 20030801
-
Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration.
Thrombosis and haemostasis 20030801
-
Improvements in the prevention of postoperative venous thromboembolism in hip fracture patients.
Orthopedics 20030801
-
Advancements in minimally invasive total knee arthroplasty.
Orthopedics 20030801
-
New drugs 2003, part II.
Nursing 20030701
-
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
Archives of internal medicine 20030609
-
Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery.
Pharmacotherapy 20030601
-
Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex.
Journal of thrombosis and haemostasis : JTH 20030601
-
[Fondaparinux for thrombosis prevention after orthopaedic surgery: a revolution?].
Medicina clinica 20030531
-
[New antithrombotic agents. Towards a new therapeutic plan].
La Revue du praticien 20030515
-
Factor X inhibitors.
Expert opinion on investigational drugs 20030501
-
The design of venous thromboembolism prophylaxis trials: is enoxaparin more effective than fondaparinux?
International journal of clinical practice 20030501
-
The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Seminars in vascular medicine 20030501
-
Low-molecular-weight heparins and heparinoids.
The Medical journal of Australia 20030421
-
Cost analysis: fondaparinux versus preoperative and postoperative enoxaparin as venous thromboembolic event prophylaxis in elective hip arthroplasty.
American journal of orthopedics (Belle Mead, N.J.) 20030401
-
[New synthetic antithrombotic agent. In secondary prevention conclusive, too].
MMW Fortschritte der Medizin 20030327
-
Fondaparinux requires further study before firm recommendation.
Archives of internal medicine 20030224
-
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
Journal of thrombosis and haemostasis : JTH 20030201
-
[New anticoagulants -- their clinical significance].
Therapeutische Umschau. Revue therapeutique 20030101
-
[New and future antithrombotic agents in thrombo-embolic venous disease].
La Revue du praticien 20030101
-
Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux).
Thrombosis research 20030101
-
Fondaparinux: a synthetic selective factor-Xa inhibitor.
Heart disease (Hagerstown, Md.) 20030101
-
[Fondaparinux and anesthesia].
Revista espanola de anestesiologia y reanimacion 20030101
-
[Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents].
Bulletin de l'Academie nationale de medecine 20030101
-
Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices.
Clinical laboratory 20030101
-
Novel anticoagulants for the prevention and treatment of venous thromboembolism.
Wiener medizinische Wochenschrift (1946) 20030101
-
Orthopedic pearls in deep vein thrombosis: questions frequently asked.
Journal of surgical orthopaedic advances 20030101
-
Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery.
Lancet (London, England) 20021123
-
Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery.
Lancet (London, England) 20021123
-
Fondaparinux versus enoxaparin for prevention of venous thromboembolism.
Lancet (London, England) 20021116
-
Fondaparinux versus enoxaparin for prevention of venous.
Lancet (London, England) 20021116
-
Fondaparinux versus enoxaparin for prevention of venous.
Lancet (London, England) 20021116
-
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers.
Circulation 20021112
-
Selective factor Xa inhibitors: practical guidelines for use.
American journal of orthopedics (Belle Mead, N.J.) 20021101
-
Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
American journal of orthopedics (Belle Mead, N.J.) 20021101
-
Use of selective factor Xa inhibitors in special populations.
American journal of orthopedics (Belle Mead, N.J.) 20021101
-
Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.
American journal of orthopedics (Belle Mead, N.J.) 20021101
-
Use of neuraxial anesthesia with selective factor Xa inhibitors.
American journal of orthopedics (Belle Mead, N.J.) 20021101
-
Fondaparinux: a new antithrombotic agent.
Clinical therapeutics 20021101
-
Traditional versus modern anticoagulant strategies: summary of the literature.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021015
-
Fondaparinux (Arixtra): a new anticoagulant.
International journal of clinical practice 20021001
-
The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery.
Archives of internal medicine 20020909
-
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Archives of internal medicine 20020909
-
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Current opinion in pulmonary medicine 20020901
-
Heparin pentasaccharide.
Current opinion in hematology 20020901
-
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.
British journal of clinical pharmacology 20020901
-
Venous thromboembolic disease prophylaxis in patients undergoing orthopedic surgery of the lower extremity.
American journal of orthopedics (Belle Mead, N.J.) 20020901
-
[Recent therapeutic strategies and new drugs].
Revue medicale de Bruxelles 20020901
-
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.
Thrombosis research 20020901
-
The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
Seminars in thrombosis and hemostasis 20020801
-
[A new synthetic coagulation inhibitor. Only half as many thromboembolisms].
MMW Fortschritte der Medizin 20020711
-
Pentasaccharides.
Seminars in hematology 20020701
-
The role of thrombin inhibition during percutaneous coronary intervention.
Pharmacotherapy 20020601
-
Optimizing prophylaxis of venous thromboembolism.
Seminars in thrombosis and hemostasis 20020601
-
Unresolved issues in the prevention and treatment of venous thromboembolism.
Seminars in thrombosis and hemostasis 20020601
-
Treatment of symptomatic venous thromboembolism: improving outcomes.
Seminars in thrombosis and hemostasis 20020601
-
Benefit of selective factor inhibition.
Seminars in thrombosis and hemostasis 20020601
-
Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention.
Lancet (London, England) 20020518
-
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lancet (London, England) 20020518
-
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
Lancet (London, England) 20020518
-
Fondaparinux (Arixtra), a new anticoagulant.
The Medical letter on drugs and therapeutics 20020513
-
Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro.
Thrombosis and haemostasis 20020501
-
Fondaparinux versus enoxaparin for the prevention of venous thromboembolism.
Expert opinion on pharmacotherapy 20020401
-
Prevention of venous thromboembolism with fondaparinux.
The New England journal of medicine 20020321
-
Prevention of venous thromboembolism with fondaparinux.
The New England journal of medicine 20020321
-
Prevention of venous thromboembolism with fondaparinux.
The New England journal of medicine 20020321
-
Prevention of venous thromboembolism with fondaparinux.
The New England journal of medicine 20020321
-
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.
Expert opinion on investigational drugs 20020301
-
Arixtra injection. FDA approves synthetic anticlotting drug.
Nursing 20020301
-
Fondaparinux sodium.
Drugs of today (Barcelona, Spain : 1998) 20020301
-
[Two new very promising antithrombotic agents: pentasaccharide and ximelagatran].
Revue medicale de la Suisse romande 20020101
-
FDA approves synthetic blood thinner.
FDA consumer 20020101
-
Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors.
Cardiovascular drug reviews 20020101
-
Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.
Progress in cardiovascular nursing 20020101
-
Fondaparinux sodium.
Drugs 20020101
-
The pharmacokinetics of fondaparinux sodium in healthy volunteers.
Clinical pharmacokinetics 20020101
-
Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins.
Clinical pharmacokinetics 20020101
-
Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
Clinical pharmacokinetics 20020101
-
The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin.
Clinical pharmacokinetics 20020101
-
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Clinical pharmacokinetics 20020101
-
Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers.
Clinical pharmacokinetics 20020101
-
Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model.
Clinical pharmacokinetics 20020101
-
Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
Reviews in cardiovascular medicine 20020101
-
Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesia.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20020101
-
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Journal of the Southern Orthopaedic Association 20020101
-
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
Journal of the Southern Orthopaedic Association 20020101
-
Cardiovascular news.
Circulation 20011127
-
Fondaparinux sodium: a selective inhibitor of factor Xa.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011101
-
Setting a standard for venous thromboembolism prophylaxis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011101
-
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
The New England journal of medicine 20011101
-
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
The New England journal of medicine 20011101
-
Choosing a parenteral anticoagulant agent.
The New England journal of medicine 20011101
-
Overview of the clinical results of pentasaccharide in major orthopedic surgery.
Haematologica 20011101